1. Home
  2. FEAM vs CTXR Comparison

FEAM vs CTXR Comparison

Compare FEAM & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEAM
  • CTXR
  • Stock Information
  • Founded
  • FEAM 2016
  • CTXR 2007
  • Country
  • FEAM United States
  • CTXR United States
  • Employees
  • FEAM N/A
  • CTXR N/A
  • Industry
  • FEAM Major Chemicals
  • CTXR Biotechnology: Pharmaceutical Preparations
  • Sector
  • FEAM Industrials
  • CTXR Health Care
  • Exchange
  • FEAM Nasdaq
  • CTXR Nasdaq
  • Market Cap
  • FEAM 32.4M
  • CTXR 28.4M
  • IPO Year
  • FEAM N/A
  • CTXR N/A
  • Fundamental
  • Price
  • FEAM $0.47
  • CTXR $3.30
  • Analyst Decision
  • FEAM Strong Buy
  • CTXR Strong Buy
  • Analyst Count
  • FEAM 2
  • CTXR 2
  • Target Price
  • FEAM $5.63
  • CTXR $54.50
  • AVG Volume (30 Days)
  • FEAM 409.6K
  • CTXR 185.5K
  • Earning Date
  • FEAM 02-12-2025
  • CTXR 02-12-2025
  • Dividend Yield
  • FEAM N/A
  • CTXR N/A
  • EPS Growth
  • FEAM N/A
  • CTXR N/A
  • EPS
  • FEAM N/A
  • CTXR N/A
  • Revenue
  • FEAM N/A
  • CTXR N/A
  • Revenue This Year
  • FEAM N/A
  • CTXR N/A
  • Revenue Next Year
  • FEAM $146.88
  • CTXR $216.25
  • P/E Ratio
  • FEAM N/A
  • CTXR N/A
  • Revenue Growth
  • FEAM N/A
  • CTXR N/A
  • 52 Week Low
  • FEAM $0.38
  • CTXR $2.44
  • 52 Week High
  • FEAM $2.48
  • CTXR $26.75
  • Technical
  • Relative Strength Index (RSI)
  • FEAM 43.74
  • CTXR 41.54
  • Support Level
  • FEAM $0.47
  • CTXR $3.70
  • Resistance Level
  • FEAM $0.75
  • CTXR $4.43
  • Average True Range (ATR)
  • FEAM 0.15
  • CTXR 0.54
  • MACD
  • FEAM -0.02
  • CTXR 0.06
  • Stochastic Oscillator
  • FEAM 3.73
  • CTXR 6.03

About FEAM 5E Advanced Materials Inc.

5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma . Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.

Share on Social Networks: